KR20100063079A - 올리고뉴클레오티드의 탐지 방법 - Google Patents

올리고뉴클레오티드의 탐지 방법 Download PDF

Info

Publication number
KR20100063079A
KR20100063079A KR1020107006245A KR20107006245A KR20100063079A KR 20100063079 A KR20100063079 A KR 20100063079A KR 1020107006245 A KR1020107006245 A KR 1020107006245A KR 20107006245 A KR20107006245 A KR 20107006245A KR 20100063079 A KR20100063079 A KR 20100063079A
Authority
KR
South Korea
Prior art keywords
primer
oligonucleotide
molecule
reverse
molecules
Prior art date
Application number
KR1020107006245A
Other languages
English (en)
Korean (ko)
Inventor
프랑소와 장-샤를르 나트
이반 보빈크
앤드류 제알
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20100063079A publication Critical patent/KR20100063079A/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/204—Modifications characterised by specific length of the oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020107006245A 2007-08-23 2008-08-21 올리고뉴클레오티드의 탐지 방법 KR20100063079A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95748707P 2007-08-23 2007-08-23
US60/957,487 2007-08-23

Publications (1)

Publication Number Publication Date
KR20100063079A true KR20100063079A (ko) 2010-06-10

Family

ID=40076846

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107006245A KR20100063079A (ko) 2007-08-23 2008-08-21 올리고뉴클레오티드의 탐지 방법

Country Status (9)

Country Link
US (1) US20110097716A1 (pt)
EP (1) EP2183390A1 (pt)
KR (1) KR20100063079A (pt)
CN (1) CN101835903A (pt)
AU (1) AU2008290545A1 (pt)
BR (1) BRPI0815725A2 (pt)
CA (1) CA2695420A1 (pt)
MX (1) MX2010002113A (pt)
WO (1) WO2009024599A1 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2821992A1 (en) 2010-10-01 2012-04-05 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
EP3395957B1 (en) 2011-04-25 2020-08-12 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
EP2717893B1 (en) 2011-06-08 2019-05-08 Translate Bio, Inc. Lipid nanoparticle compositions and methods for mrna delivery
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
ES2911677T3 (es) 2011-10-03 2022-05-20 Modernatx Inc Nucleósidos, nucleótidos y ácidos nucleicos modificados, y sus usos
DE12858350T1 (de) 2011-12-16 2021-10-07 Modernatx, Inc. Modifizierte mrna zusammensetzungen
ES2842938T3 (es) * 2012-01-11 2021-07-15 Ionis Pharmaceuticals Inc Composiciones y métodos para la modulación del empalme de IKBKAP
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
EP3501550A1 (en) 2012-04-02 2019-06-26 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
US11390907B2 (en) 2013-03-05 2022-07-19 Agilent Technologies, Inc. Synthesis of pools of probes by primer extension
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2014145620A2 (en) * 2013-03-15 2014-09-18 The Broad Institute, Inc. Novel hybridization probes and uses thereof
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052521A1 (en) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
US11162096B2 (en) 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
CA2995110A1 (en) * 2015-08-14 2017-02-23 University Of Massachusetts Bioactive conjugates for oligonucleotide delivery
PL3350157T3 (pl) 2015-09-17 2022-05-16 Modernatx, Inc. Związki i kompozycje do dostarczania wewnątrzkomórkowego środków terapeutycznych
DK3386484T3 (da) 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
JP7114465B2 (ja) 2015-12-22 2022-08-08 モデルナティエックス インコーポレイテッド 薬剤の細胞内送達のための化合物および組成物
US9617587B1 (en) * 2016-04-04 2017-04-11 Nat Diagnostics, Inc. Isothermal amplification components and processes
EP3523435A1 (en) * 2016-10-07 2019-08-14 Secarna Pharmaceuticals GmbH & Co. KG Immunosuppression-reverting oligonucleotides inhibiting the expression of cd39
US11583504B2 (en) 2016-11-08 2023-02-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
US11085071B2 (en) 2017-02-01 2021-08-10 Spot Biosystems Ltd. Highly stable and specific molecular beacons encapsulated in cationic lipoplex nanoparticles and application thereof
FI3596041T3 (fi) 2017-03-15 2023-01-31 Yhdiste ja koostumuksia terapeuttisten aineiden antamiseen solun sisään
JP7332478B2 (ja) 2017-03-15 2023-08-23 モデルナティエックス インコーポレイテッド 脂質ナノ粒子製剤
DK3596042T3 (da) 2017-03-15 2022-04-11 Modernatx Inc Krystalformer af aminolipider
WO2018232357A1 (en) 2017-06-15 2018-12-20 Modernatx, Inc. Rna formulations
WO2019046809A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES
CA3124763A1 (en) * 2019-01-03 2020-07-09 Dna Script One pot synthesis of sets of oligonucleotides
CN109913534A (zh) * 2019-01-24 2019-06-21 中国药科大学 一种基于级联DNA链循环反应和荧光共振能量转移效应的两种miRNA同时检测的方法
CN109868309B (zh) * 2019-03-05 2022-11-11 苏州恩可医药科技有限公司 基于通用碱基替换插入的单链dna扩增方法
WO2021030213A1 (en) 2019-08-09 2021-02-18 University Of Massachusetts Chemically modified oligonucleotides targeting snps
CN114728887A (zh) 2019-09-19 2022-07-08 摩登纳特斯有限公司 用于治疗剂的细胞内递送的支链尾端脂质化合物和组合物
CN111500676B (zh) * 2020-04-21 2022-09-09 桂林旅游学院 一种将寡聚核苷酸逆转录成cDNA的方法及寡聚核苷酸检测方法
US11524023B2 (en) 2021-02-19 2022-12-13 Modernatx, Inc. Lipid nanoparticle compositions and methods of formulating the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575863B2 (en) * 2004-05-28 2009-08-18 Applied Biosystems, Llc Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
US20060057595A1 (en) * 2004-09-16 2006-03-16 Applera Corporation Compositions, methods, and kits for identifying and quantitating small RNA molecules
AU2006208134A1 (en) * 2005-01-25 2006-08-03 Rosetta Inpharmatics Llc Methods for quantitating small RNA molecules

Also Published As

Publication number Publication date
WO2009024599A1 (en) 2009-02-26
MX2010002113A (es) 2010-03-26
US20110097716A1 (en) 2011-04-28
CA2695420A1 (en) 2009-02-26
CN101835903A (zh) 2010-09-15
BRPI0815725A2 (pt) 2015-02-10
EP2183390A1 (en) 2010-05-12
AU2008290545A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
KR20100063079A (ko) 올리고뉴클레오티드의 탐지 방법
Turner et al. MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity
Li et al. MicroRNAs as novel biological targets for detection and regulation
EP3358014B1 (en) Method for stabilizing functional nucleic acids
JP2020188771A (ja) 二本鎖ＲＮＡによるα−１アンチトリプシンの特異的阻害のための方法及び組成物
US8318921B2 (en) Triggered RNAi
US20110207132A1 (en) Probes and methods for detecting analytes
CN101849008A (zh) 用于减少RNAi中的脱靶表型效应的siRNA的不依赖于序列的修饰形式和其稳定形式
US10695362B2 (en) Stabilization method of functional nucleic acid
US20220073921A1 (en) Aptamer and use of the aptamer in the diagnosis and treatment of cancer
KR102141312B1 (ko) 짧은 RNA-primed 제노 센서 모듈 증폭 기반 짧은 RNA 탐지 기법
KR20130099092A (ko) 광을 이용한 핵산의 증폭 억제 방법 및 고감도의 선택적 핵산 증폭 방법
Remaut et al. FRET-FCS as a tool to evaluate the stability of oligonucleotide drugs after intracellular delivery
Quan et al. An Endogenous miRNA-Initiated Hybridization Chain Reaction and Subsequent DNAzyme Activation for Cellular Theranostics
US20140309280A1 (en) Assays for micro-rna-182 as a biomarker for muscle atrophy and therapeutic applications
KR20190137718A (ko) 회전환 증폭을 이용한 표적핵산 검출 방법 및 표적핵산 검출용 조성물
US20080045471A1 (en) Nucleic Acids For Apoptosis Of Cancer Cells
DE60002967T2 (de) Pseudo-cyclische oligonukleobasen
Hai-Long et al. Quantitative detection of PremicroRNA-21 based on chimeric molecular beacon
KR102384471B1 (ko) Lna 프로브와 산화그래핀의 복합체 및 이를 이용한 핵산 검출 방법
WO2024110565A1 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
EP4149623A1 (en) Compositions and methods for treating and detecting coronavirus infection
EP3216866B1 (en) Clamping probe
TW202122095A (zh) Ｒｎａ作用抑制劑及其利用
WO2024115635A1 (en) Antisense oligonucleotides for the treatment of aldehyde dehydrogenase 2 deficiency

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application